aspartic acid has been researched along with transforming growth factor alpha in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jordan, VC; Levenson, AS | 1 |
| Bentrem, DJ; Jordan, VC; Liu, H; MacGregor Schafer, J; Zapf, JW | 1 |
| Jordan, VC; Liu, H; Pearce, ST | 1 |
| Hato, M; Hirata, K; Hori, T; Kawano, Y; Miyano, M; Nakamura, M; Okuno, T; Shimizu, T; Yamamoto, M; Yamashita, K; Yokomizo, T; Yokoyama, S | 1 |
4 other study(ies) available for aspartic acid and transforming growth factor alpha
| Article | Year |
|---|---|
The key to the antiestrogenic mechanism of raloxifene is amino acid 351 (aspartate) in the estrogen receptor.
Topics: Aspartic Acid; Blotting, Northern; Breast Neoplasms; Estradiol; Estrogen Antagonists; Female; Humans; Mutagenesis, Site-Directed; Piperidines; Point Mutation; Raloxifene Hydrochloride; Receptors, Estrogen; RNA, Messenger; Transfection; Transforming Growth Factor alpha; Tumor Cells, Cultured | 1998 |
Allosteric silencing of activating function 1 in the 4-hydroxytamoxifen estrogen receptor complex is induced by substituting glycine for aspartate at amino acid 351.
Topics: Allosteric Regulation; Amino Acid Substitution; Aspartic Acid; Binding Sites; Drug Interactions; Estradiol; Estrogen Receptor Modulators; Fulvestrant; Glycine; Humans; Kinetics; Ligands; Mutagenesis, Site-Directed; Protein Conformation; Protein Structure, Tertiary; Raloxifene Hydrochloride; Receptors, Estrogen; RNA, Messenger; Tamoxifen; Transfection; Transforming Growth Factor alpha; Tumor Cells, Cultured | 2000 |
Modulation of estrogen receptor alpha function and stability by tamoxifen and a critical amino acid (Asp-538) in helix 12.
Topics: Aspartic Acid; Blotting, Northern; Blotting, Western; Cell Line; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Fulvestrant; Humans; Ligands; Luciferases; Models, Molecular; Mutagenesis, Site-Directed; Mutation; Protein Binding; Protein Conformation; Protein Structure, Secondary; Protein Structure, Tertiary; Receptors, Estrogen; RNA, Messenger; Tamoxifen; Time Factors; Transcription, Genetic; Transfection; Transforming Growth Factor alpha; Tumor Cells, Cultured | 2003 |
Na
Topics: Allosteric Site; Amidines; Animals; Aspartic Acid; Binding Sites; Crystallography, X-Ray; Drug Design; Guinea Pigs; HEK293 Cells; Humans; Inositol Phosphates; Leukotriene B4; Ligands; Protein Binding; Protein Domains; Receptors, Leukotriene B4; Transforming Growth Factor alpha | 2018 |